Literature DB >> 12048112

Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain.

Hong-Bing Yao1, Pang-Chui Shaw, Chun-Cheung Wong, David Chi-Cheong Wan.   

Abstract

Glycogen synthase kinase-3alpha and -3beta (GSK-3alpha and -3beta) are multi-substrate, serine/threonine-specific kinases that can phosphorylate microtubule-associated protein tau and other neuronal proteins. In this study, the expression level and mRNA distribution of two GSK-3 isoforms, GSK-3alpha and -3beta in mice were investigated. Northern blot analyses indicated that GSK-3alpha mRNA is encoded by a 2.5-kb transcript in adult tissues, whereas a 4.1-kb transcript was found in neonatal tissues. The GSK-3beta mRNA is encoded by a 1.6-kb transcript in the testis and a 7.6-kb transcript in the brain, and in many other adult tissues, but not neonatal tissues. Western blot analyses demonstrated that GSK-3beta protein was mainly expressed in the brain and heart, whereas GSK-3alpha was highly expressed in the brain, heart, and testis. A non-radioactive in situ hybridization study using specific digoxigenin-labeled RNA probes showed that GSK-3alpha and -3beta mRNAs were found in many brain regions, and were especially abundant in the hippocampus, cerebral cortex, and the Purkinje cells of the cerebellum. This implies the importance of GSK-3alpha and -3beta for brain function. The differential expression of GSK-3alpha and -3beta mRNAs as well as proteins in other tissues indicate that they play different roles in cellular functions and the developmental process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048112     DOI: 10.1016/s0891-0618(02)00014-5

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  45 in total

1.  Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.

Authors:  David E Hurtado; Laura Molina-Porcel; Jenna C Carroll; Caryn Macdonald; Awo K Aboagye; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

2.  Differential Roles of Accumbal GSK3β in Cocaine versus Morphine-Induced Place Preference, U50,488H-Induced Place Aversion, and Object Memory.

Authors:  Xiangdang Shi; Jeffrey L Barr; Eva von Weltin; Cassandra Wolsh; Ellen M Unterwald
Journal:  J Pharmacol Exp Ther       Date:  2019-08-16       Impact factor: 4.030

3.  Targeted disruption of glycogen synthase kinase 3A (GSK3A) in mice affects sperm motility resulting in male infertility.

Authors:  Rahul Bhattacharjee; Suranjana Goswami; Tejasvi Dudiki; Anthony P Popkie; Christopher J Phiel; Douglas Kline; Srinivasan Vijayaraghavan
Journal:  Biol Reprod       Date:  2015-01-07       Impact factor: 4.285

4.  Folic Acid Protects Against Glutamate-Induced Excitotoxicity in Hippocampal Slices Through a Mechanism that Implicates Inhibition of GSK-3β and iNOS.

Authors:  Josiane Budni; Simone Molz; Tharine Dal-Cim; Maria Dolores Martín-de-Saavedra; Javier Egea; Manuela G Lopéz; Carla Ines Tasca; Ana Lúcia Severo Rodrigues
Journal:  Mol Neurobiol       Date:  2017-02-10       Impact factor: 5.590

Review 5.  Mechanisms of action of brain insulin against neurodegenerative diseases.

Authors:  Mahesh Ramalingam; Sung-Jin Kim
Journal:  J Neural Transm (Vienna)       Date:  2014-01-09       Impact factor: 3.575

6.  Glycogen synthase kinase-3β regulates tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis via the NF-κB pathway in hepatocellular carcinoma.

Authors:  Kai Fu; Huazheng Pan; Shihai Liu; Jing Lv; Zhaojun Wan; Jiao Li; Qing Sun; Jun Liang
Journal:  Oncol Lett       Date:  2015-10-13       Impact factor: 2.967

Review 7.  GSK3 in Alzheimer's disease: mind the isoforms.

Authors:  Tao Ma
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.

Authors:  Olivia O'Leary; Yvonne Nolan
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

Review 9.  Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer.

Authors:  Michelle J Lee; Nan Jin; Jennifer R Grandis; Daniel E Johnson
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-02-19       Impact factor: 4.739

10.  Glycogen synthase kinase 3beta interaction protein functions as an A-kinase anchoring protein.

Authors:  Christian Hundsrucker; Philipp Skroblin; Frank Christian; Hans-Michael Zenn; Viola Popara; Mangesh Joshi; Jenny Eichhorst; Burkhard Wiesner; Friedrich W Herberg; Bernd Reif; Walter Rosenthal; Enno Klussmann
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.